Biodis is the name of this biotechnology distributor that will launch their new product to many countries of the world. Citofem is the name of the actual test.
"There are only two major pap smear products on the market today, now with Citofem(R), there is a third. This Pap test kit however, offers the highest sensitivity at the lowest price, making this a powerful weapon in the battle against cervical cancer worldwide," said Kent Erickson, Vice President of Sales for North America.
Why is this screening pap smear product better than the other two on the market? Citofem give the same superior results as the other two previous tests but it allows for a manual procedure that is very easy to replaces the purchase of expensive lab equipment.The process is extremely efficient with a single cytotechnologist processing on average over 750 slides per day.
Citofem results in a significant reduction in false negatives, increasing the diagnosis of the disease in its early stages," said Dr. Ladly Abraham, Chief Medical Officer of Biodis. "Citofem is also responsible for a reduction in inconclusive results arising from atypical squamous cells (ASC). It also results in the increased level of detection of low grade squamous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL). We're very excited about Citofem because it's the most complete system for the early detection of cervical cancer, in that it obtains a much higher population of endocervical cells in the sample."
For more info:
http://www.marketwatch.com/story/revolutionary-new-cervical-cancer-screening-test-to-hit-worldwide-market-2012-05-02
BIOTD THE MANUFACTURER OF CITOFEM IS CURRENTLY BEING SUED IN HEREDIA, COSTA RICA FOR BREACH OF INTERNATIONAL DISTRIBUTION CONTRACT IN EXCESS OF ONE BILLION DOLLARS.
ReplyDelete